Complement C5a is a key mediator of meconium-induced neutrophil activation

Albert Castellheim1, Anne Pharo, Michael Fung

  • 1Department of Pediatric Research, Rikshospitalet University Hospital, 0027 Oslo, Norway. albert.castellheim@klinmed.uio.no

Pediatric Research
|December 9, 2004
PubMed

Insights

Meconium strongly activates neutrophils, a key part of newborn inflammation. Complement activation, particularly C5a, drives this response, offering potential therapeutic targets for meconium aspiration syndrome.

Area of Science:

  • Neonatal immunology
  • Complement system biology
  • Inflammatory response mechanisms

Background:

  • Meconium aspiration syndrome (MAS) involves severe newborn lung inflammation with neutrophil infiltration.
  • Meconium is a known potent activator of the complement system.
  • The specific role of complement in meconium-induced neutrophil activation requires further investigation.

Purpose of the Study:

  • To investigate the role of the complement system in mediating neutrophil activation by meconium.
  • To identify key complement components involved in the inflammatory response to meconium.

Main Methods:

  • Incubation of meconium in human whole blood with complement activation.
  • Measurement of complement activation via terminal complement complex detection.
  • Assessment of neutrophil activation (oxidative burst, CD11b and L-selectin expression) using flow cytometry.
  • Inhibition of complement activation using specific monoclonal antibodies against Factor D and C5a.

Main Results:

  • Meconium induced significant neutrophil activation, including CD11b up-regulation, L-selectin shedding, and oxidative burst.
  • Inhibition of Factor D completely blocked CD11b and L-selectin changes and reduced oxidative burst by 60-70%.
  • Neutralization of C5a demonstrated similar inhibitory effects on neutrophil activation as Factor D inhibition.
  • Complement activation is largely responsible for meconium-induced neutrophil inflammatory responses in vitro.

Conclusions:

  • Complement activation plays a critical role in meconium-induced neutrophil inflammation in newborns.
  • C5a is identified as a key mediator in the complement-driven inflammatory response to meconium.
  • Targeting the complement system, specifically C5a, may offer therapeutic strategies for MAS.

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Inflammation01:38

Inflammation

Overview
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...